SmartNuclide

SmartNuclide® (Suzhou Smart Nuclear Biological Pharmaceutical Technology Co., Ltd.), founded in 2015, is a nuclear medicine company with the mission of "bringing new hope to patients through the most innovative nuclear medicine diagnosis and treatment products." It is committed to providing innovative radiopharmaceuticals for patients worldwide, covering areas such as thyroid cancer, breast cancer, and tumor-related diagnostic and therapeutic radiopharmaceuticals.